Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
Abstract
The cholinergic system is involved in the regulation of all organ systems and has acetylcholine (ACh) as almost its only neurotransmitter. Any substance is called cholinergic if it can alter the action of acetylcholine. Cholinesterases (ChEs) are enzymes that enable the hydrolysis of acetylcholine and in this way ensure homeostasis in cholinergic synapses. Cholinesterase inhibitors (ChEi) are a group of indirect-acting cholinergic agonists that influence the activity of the cholinergic system. Several compounds that can inhibit cholinesterases are of importance to veterinary medicine from pharmacological and toxicological perspective. The frequency of their use in veterinary medicine has fluctuated over the years and is now reduced to a minimum. They are mainly used in agriculture as pesticides, and some are rarely used as parasiticides for companion animals and livestock. In recent years, interest in the use of new cholinesterase inhibitors has increased since canine cognitive dysfunction (CCD) became a recognized and extensively studied disease. Similar to Alzheimer’s disease (AD) in humans, CCD can be treated with cholinesterase inhibitors that cross the blood–brain barrier. In this review, the mammalian cholinergic system and the drugs that interact with cholinesterases are introduced. Cholinesterase inhibitors that can be used for the treatment of CCD are described in detail.
Keywords
cholinergic system;cholinesterase inhibitors;organophosphates;carbamates;canine cognitive dysfunction;cognitive dysfunction;dogs;
Data
| Language: | English |
|---|---|
| Year of publishing: | 2023 |
| Typology: | 1.02 - Review Article |
| Organization: | UL VF - Veterinary Faculty |
| UDC: | 636.09:577:612 |
| COBISS: |
144140035
|
| ISSN: | 2297-1769 |
| Views: | 314 |
| Downloads: | 54 |
| Average score: | 0 (0 votes) |
| Metadata: |
|
Other data
| Secondary keywords: | Cholinesterase Inhibitors;Organophosphates;Carbamates;Cognitive Dysfunction;Dogs; |
|---|---|
| Type (COBISS): | Article |
| Pages: | str. 1-11 |
| Issue: | ǂVol. ǂ10, [article no.] 1125618 |
| Chronology: | 2023 |
| DOI: | 10.3389/fvets.2023.1125618 |
| ID: | 18177096 |
Recommended works:
Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
2023,
no subtitle data available
Canine cognitive dysfunction and Alzheimerʼs disease
2019,
two facets of the same disease?
Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor
2021,
no subtitle data available
From tryptophan-based amides to tertiary amines
2022,
optimization of a butyrylcholinesterase inhibitor series
Nitrosative stress in the frontal cortex from dogs with canine cognitive dysfunction
2020,
no subtitle data available